Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 12 » default

Blood and Lymphatic Cancer: Targets and Therapy


Archive: Volume 12, 2022

HIV/AIDS Associated Lymphoma: Review

Berhan A, Bayleyegn B, Getaneh Z

Blood and Lymphatic Cancer: Targets and Therapy 2022, 12:31-45

Published Date: 29 April 2022

Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma

Kuhlman JJ, Alhaj Moustafa M, Jiang L, Wang J, Gupta V, Tun HW

Blood and Lymphatic Cancer: Targets and Therapy 2022, 12:23-29

Published Date: 14 April 2022

Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation

Kase AM, Bullock C, Parrondo R, Alhaj Moustafa M, Iqbal M, Li KD, Parent EE, Tun H

Blood and Lymphatic Cancer: Targets and Therapy 2022, 12:17-21

Published Date: 23 March 2022

Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia

Hein K, Short N, Jabbour E, Yilmaz M

Blood and Lymphatic Cancer: Targets and Therapy 2022, 12:7-16

Published Date: 19 March 2022